Stock Market News

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial

May 31, 2025 - 13:22
 0
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
Read More

Tags:

Previous Article

Shoe Carnival's Transformation Offers Upside

Next Article

3 Magnificent Dividend Stocks Down 15% to 64% to Buy and Hold for 20 Years

Related Posts

HSBC scales back U.S. small business banking services - WSJ

HSBC scales back U.S. small business banking services -...

May 30, 2025  0

No place to hide from any China-Taiwan conflict, investors say

No place to hide from any China-Taiwan conflict, invest...

May 22, 2025  0

Tencent: Bernstein, Mizuho hike PT as Q1 beat shows AI strength

Tencent: Bernstein, Mizuho hike PT as Q1 beat shows AI ...

May 15, 2025  0